Clinical Trials Logo

Clinical Trial Summary

"Sore throat is one of the most common complaints encountered in clinical practice. And in 65% of cases, the infection is thought to be viral in nature.

The aim of this study is to evaluate the analgesic profile of 3 Ibuprofen lozenges after single administration in acute sore throat pain."


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT01535079
Study type Interventional
Source Pierre Fabre Medicament
Contact
Status Completed
Phase Phase 2
Start date February 2012
Completion date November 2012

See also
  Status Clinical Trial Phase
Completed NCT01785862 - Ibuprofen Lozenge in Acute Sore Throat Pain Phase 3